[13E5-13E5];[13F7-13F7];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
13E5;13F7
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
1: P{XP}CG12708d04821
2: PBac{RB}CG32582e03916
The presence of P+PBac{XP5.RB3}BSC629 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(1)BSC629 predicted from the Release 5 genomic coordinates of the insertions sites of the progenitor P{XP}CG12708d04821 and PBac{RB}CG32582e03916 transposable elements are 13E5;13F7.